KRAS inhibitor-10
Product Specifications
UNSPSC Description
KRAS inhibitor-10 (compound 11) selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a?tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-inhibitor-10.html
Smiles
O=C(N1C(C2=CC=C(OC)C=C2C)C3=C(C=C(OC)C(OCCC4=CC=C(OC)C(N)=C4)=C3)CC1)NCC
Molecular Weight
519.63
References & Citations
[1]Miguel VEGA GARCÍA, et al. Tetrahydroisoquinoline compounds. Patent wo2021002165
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-138295/KRAS-inhibitor-10-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-138295/KRAS-inhibitor-10-SDS-MedChemExpress.pdf
CAS Number
2578876-75-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6391284-01 0.1 mL
PTGDR (PGD2 Receptor, PGD Receptor, Prostaglandin D2 Receptor, AS1, ASRT1, DP, DP1, MGC49004, Prostanoid DP Receptor, MGC49004) (MaxLight 750)
Ask
View Details MBS6391284-02 5x 0.1 mL
PTGDR (PGD2 Receptor, PGD Receptor, Prostaglandin D2 Receptor, AS1, ASRT1, DP, DP1, MGC49004, Prostanoid DP Receptor, MGC49004) (MaxLight 750)
Ask
View Details 